News and Articles on Ayurveda, Yoga, Kundalini and other Indian way of health and medicines.
Indian researchers have designed a robust, mobile group oxygen concentrator that can be used in rural settings and also be rapidly deployed in emergencies in any location.
About 50 countries, including Canada, Mexico, Nigeria and Panama, have shown interest in having a Co-WIN like system to run their vaccination drive, a senior official said Monday, adding India is ready to share the open source software free of cost.
Fulfilling its commitment, Serum Institute of India has produced over 10 crore doses of its Covid-19 vaccine Covishield in June so far as India ramps up the pace of its vaccination drive in the face of a possible third wave of the viral infection.
The Indian Institute of Technology in Delhi (IIT Delhi) on Friday launched a rapid diagnostic kit for conducting Covid-19 test at a price point of Rs50 apiece.
A software can now identify patients likely to require ventilator support in an ICU and referral in time and make necessary arrangements before emergency sets in. The software called Covid Severity Score (CSS) Software consists of an algorithm that measures a set of parameters. It scores each against a pre-set dynamic algorithm multiple times for each patient and allocates a Covid Severity Score (CSS) mapping it in a graphical trend.
A new research suggests that Yoga in addition to standard antidepressant treatment can bring relief to patients with Major Depressive Disorder (MDD)both clinically and biologically and can also bring about earlier remission.
A DNA vaccine carries into the body the genetic code for that part of a virus that triggers the immune system of the body. The message is decoded using the host cell’s own machinery to produce that antigen and stimulate the immune system. This ensures that later on when an actual infection occurs and the SARS-CoV2 enters the body, the immune system is already prepped to recognise it and knows what are the most effective ways to fight it.
Weinnovate Biosolutions was supported by CAWACH (Centre for Augmenting War with COVID-19 Health Crisis) 2020 grant from the National Science and Technology Entrepreneurship Development Board (NSTEDB) under the Department of Science and Technology (DST) and the project was incubated at Entrepreneurship Development Centre, Pune.
Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd., Hyderabad, have been given the regulatory approval by the Drugs Controller General of India (DCGI) to undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the drug Colchicine in the improvement of clinical outcomes during the treatment of COVID-19 patients. The partner CSIR institutes in this important clinical trial are the CSIR-Indian Institute of Chemical Technology (IICT), Hyderabad and CSIR-Indian Institute of Integrative Medicine (IIIM), Jammu.
The study conducted on 100 Chronic Low Back Pain (CLBP) patients of 50 years with 3 years of history of the disease. After systematic Yogic intervention of 4 weeks, Quantitative sensory testing (QST) showed increase in thresholds for cold pain and cold pain tolerance. Corticomotor excitability and flexibility improved significantly in the patients.
